发明名称 |
Ureteral stent drug delivery device, kit, and method |
摘要 |
Ureteral stent devices having improved drug delivery capabilities are provided. The ureteral stent device includes a ureteral stent comprising two opposed ends, and a drug delivery component associated with at least one end of the ureteral stent. The drug delivery component includes a drug housing defining a drug reservoir containing a drug, wherein the drug housing is configured to release the drug in-vivo. |
申请公布号 |
US9492266(B2) |
申请公布日期 |
2016.11.15 |
申请号 |
US201113813973 |
申请日期 |
2011.08.05 |
申请人 |
TARIS Biomedical LLC |
发明人 |
Hutchins, III Burleigh M.;Larrivee-Elkins Cheryl;Lee Heejin;Boyko Jim |
分类号 |
A61F2/04;A61F2/06;A61M27/00;A61M25/00 |
主分类号 |
A61F2/04 |
代理机构 |
Sutherland Asbill & Brennan LLP |
代理人 |
Sutherland Asbill & Brennan LLP |
主权项 |
1. An implantable medical device, comprising:
a ureteral stent comprising an elongated central body having an internal lumen extending between a kidney-residing end and an opposed bladder-residing end of the ureteral stent; and a drug delivery component extending from the bladder-residing end of the ureteral stent, wherein the drug delivery component has a proximal end attached to the ureteral stent and a distal end spaced apart from the ureteral stent, wherein the drug delivery component comprises a drug housing defining a drug reservoir containing a drug in solid or semi-solid form, wherein the drug housing is configured to release the drug in vivo, and wherein the drug reservoir is fluidly separate and spaced apart from the internal lumen of the ureteral stent. |
地址 |
Lexington MA US |